Combined erythropoietin and iron therapy for anaemic patients undergoing transcatheter aortic valve implantation: the EPICURE randomised clinical trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of this study was to evaluate, in anaemic patients, the efficacy of erythropoietin (EPO) in reducing red cell (RC) transfusion rates post TAVI.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): EuroIntervention

Title: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Publisher: Europa Digital & Publishing

ISSN (Electronic): 1969-6213

ISSN (Print): 1774-024X

Publication date (Electronic): May 15 2017

Volume: 13

Issue: 1

Affiliations

[1 ] Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Article

Publisher Item ID: EIJ-D-16-00591

DOI: 10.4244/EIJ-D-16-00591

PubMed ID: 28067195

SO-VID: d35e6c0e-824d-4927-b5d2-035bb503dc74

History

Data availability:

Comments

Comment on this article

scite_

Cited by 12

See all cited by